Cited by 359Alzheimer's disease research and treatmentsParkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research

Alzheimer Disease With Amygdala Lewy Bodies: A Distinct Form of α-Synucleinopathy

Open access
Uchikado, Hirotake, Lin, Wen-Lang, DeLucia, Michael W., Dickson, Dennis W.·2006·Journal of Neuropathology and Experimental Neurology

Abstract

Lewy bodies (LBs) are alpha-synuclein-immunoreactive neuronal inclusions with a predilection for specific cortical and subcortical regions, including the amygdala. In this study, the presence of LBs was assessed in 347 cases of Alzheimer disease (AD). In 87 cases, LB pathology was diagnostic of brainstem (n=3), transitional (n=32), or diffuse (n=52) Lewy body disease (LBD). The remaining 260 cases of AD were screened for amygdala LBs (AD/ALB) and 62 (24%) cases were found. If AD/LBD cases are included, LBs were detected in 149 (43%) cases of AD. The presence alpha-synuclein pathology was assessed in multiple brain regions of the 62 cases of AD/ALB and 57 randomly selected cases of AD, and only sparse alpha-synuclein pathology was detected in both. The burden of alpha-synuclein pathology in brainstem nuclei, amygdala, and neocortex was significant lower in AD/ALB than in AD/LBD. In comparison to AD/LBD, AD/ALB did not differ in age at death, disease duration, male-to-female ratio, brain weight, Braak neurofibrillary tangle stage, average senile plaque density, or apolipoprotein E epsilon4 allele frequency. The results suggest that AD/ALB is pathologically different from AD/LBD, suggesting that it is a neuropathologically distinct and isolated alpha-synucleinopathy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/01.jnen.0000225908.90052.07

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 46

  1. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop. Neurology 1996;47:1113 Y24
  2. Dickson DW, Crystal HA, Mattiace LA, et al. Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol Aging 1992;13:179 Y89
  3. Hyman BT, Trojanowski JQ. Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J Neuro- pathol Exp Neurol 1997;56:1095 Y97
  4. Hansen L, Salmon D, Galasko D, et al. The Lewy body variant of Alzheimer_s disease: a clinical and pathologic entity. Neurology 1990; 40:1 Y8
  5. Mikolaenko I, Pletnikova O, Kawas CH, et al. Alpha-synuclein lesions in normal aging, Parkinson disease, and Alzheimer disease: evidence from the Baltimore Longitudinal Study of Aging (BLSA). J Neuro- pathol Exp Neurol 2005;64:156 Y 62
  6. Parkkinen L, Soininen H, Alafuzoff I. Regional distribution of alpha-synuclein pathology in unimpaired aging and Alzheimer disease. J Neuropathol Exp Neurol 2003;62:363 Y 67
  7. Saito Y, Kawashima A, Ruberu NN, et al. Accumulation of phosphory- lated alpha-synuclein in aging human brain. J Neuropathol Exp Neurol 2003;62:644 Y54
  8. Dickson DW. Alpha-synuclein and the Lewy body disorders. Curr Opin Neurol 2001;14:423 Y 32
  9. Jellinger KA. Alpha-synuclein pathology in Parkinson_s and Alzheimer_s disease brain: incidence and topographic distributionVa pilot study. Acta Neuropathol (Berl) 2003;106:191 Y 201
  10. Hamilton RL. Lewy bodies in Alzheimer_s disease: a neuropatholog- ical review of 145 cases using alpha-synuclein immunohistochemistry. Brain Pathol 2000;10:378 Y84
  11. Marui W, Iseki E, Ueda K, et al. Occurrence of human alpha-synuclein immunoreactive neurons with neurofibrillary tangle formation in the limbic areas of patients with Alzheimer_s disease. J Neurol Sci 2000;174: 81 Y84
  12. Schmidt ML, Martin JA, Lee VM, Trojanowski JQ. Convergence of Lewy bodies and neurofibrillary tangles in amygdala neurons of Alzheimer_s disease and Lewy body disorders. Acta Neuropathol (Berl) 1996;91:475 Y81
  13. Lippa CF, Schmidt ML, Lee VM, et al. Antibodies to alpha-synuclein detect Lewy bodies in many Down_s syndrome brains with Alzheimer_s disease. Ann Neurol 1999;45:353 Y57
  14. Rezaie P, Cairns NJ, Chadwick A, et al. Lewy bodies are located pref- erentially in limbic areas in diffuse Lewy body disease. Neurosci Lett 1996;212:111 Y14
  15. Marui W, Iseki E, Nakai T, et al. Progression and staging of Lewy pathology in brains from patients with dementia with Lewy bodies. J Neurol Sci 2002;195:153 Y59
  16. Harding AJ, Broe GA, Halliday GM. Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. Brain 2002; 125:391 Y 403
  17. Hopper MW, Vogel FS. The limbic system in Alzheimer_s disease. A neuropathologic investigation. Am J Pathol 1976;85:1 Y20
  18. Mann DM, Yates PO, Marcyniuk B, et al. The topography of plaques and tangles in Down_s syndrome patients of different ages. Neuropathol Appl Neurobiol 1986;12:447 Y57
  19. Vereecken TH, Vogels OJ, Nieuwenhuys R. Neuron loss and shrinkage in the amygdala in Alzheimer_s disease. Neurobiol Aging 1994;15:45 Y54
  20. Tsuchiya K, Kosaka K. Neuropathological study of the amygdala in presenile Alzheimer_s disease. J Neurol Sci 1990;100:165 Y73
  21. Zald DH. The human amygdala and the emotional evaluation of sensory stimuli. Brain Res Brain Res Rev 2003;41:88 Y123
  22. Rolls E. Neurophysiology and functions of the primate amygdala. In: Aggleton JP, ed. The Amygdala. New York: Wiley-Liss, 1992:143 Y 65
  23. Barker WW, Luis CA, Kashuba A, et al. Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank. Alzheimer Dis Assoc Disord 2002;16:203 Y12
  24. Khachaturian ZS. Diagnosis of Alzheimer_s disease. Arch Neurol 1985; 42:1097 Y105
  25. Gloor P. The amygdala system. In: Gloor P, ed. The Temporal Lobe and Limbic System. New York: Oxford University Press, 1997:591 Y721
  26. Gwinn-Hardy K, Mehta ND, Farrer M, et al. Distinctive neuropathology revealed by alpha-synuclein antibodies in hereditary parkinsonism and dementia linked to chromosome 4p. Acta Neuropathol (Berl) 2000; 99:663 Y72
  27. Uchikado H, Delledonne A, Uitti R, Dickson DW. Coexistence of PSP and MSA: A case report and review of the literature. Acta Neuropathol (Berl) 2006;111:186 Y92
  28. Lin WL, Lewis J, Yen SH, Hutton M, Dickson DW. Filamentous tau in oligodendrocytes and astrocytes of transgenic mice expressing the human tau isoform with the P301L mutation. Am J Pathol 2003;162:213 Y18
  29. Crook R, Hardy J, Duff K. Single-day apolipoprotein E genotyping. J Neurosci Methods 1994;53:125 Y27
  30. Baker M, Litvan I, Houlden H, et al. Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum Mol Genet 1999;8:7111 Y15
  31. Braak H, Del Tredici K, Rub U, et al. Staging of brain pathology related to sporadic Parkinson_s disease. Neurobiol Aging 2003;24:197 Y211
  32. Perry RH, Irving D, Blessed G, et al. Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly. J Neurol Sci 1990;95:119 Y39
  33. Kosaka K. Diffuse Lewy body diseases in Japan. J Neurol 1990;237: 197 Y204
  34. Uchikado H, DelleDonne A, Ahmed Z, Dickson DW. Lewy bodies in progressive supranuclear palsy represent an independent disease process. J Neuropathol Exp Neurol 2006;65:387 Y95
  35. Marui W, Iseki E, Kato M, et al. Pathological entity of dementia with Lewy bodies and its differentiation from Alzheimer_s disease. Acta Neuropathol (Berl) 2004;108:121 Y28
  36. Geddes JW. Alpha-synuclein: A potent inducer of tau pathology. Exp Neurol 2005;192:244 Y50
  37. Iseki E, Marui W, Kosaka K, et al. Frequent coexistence of Lewy bodies and neurofibrillary tangles in the same neurons of patients with diffuse Lewy body disease. Neurosci Lett 1999;265:9 Y12
  38. Iseki E, Takayama N, Marui W, et al. Relationship in the formation process between neurofibrillary tangles and Lewy bodies in the hip- pocampus of dementia with Lewy bodies brains. J Neurol Sci 2002;195: 85 Y91
  39. Saito Y, Ruberu NN, Sawabe M, et al. Lewy body-related alpha- synucleinopathy in aging. J Neuropathol Exp Neurol 2004; 63:742 Y49
  40. Pletnikova O, West N, Lee MK, et al. Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in Lewy body diseases. Neurobiol Aging 2005;26:1183 Y92
  41. Lewis J, Dickson DW, Lin WL, et al. Enhanced neurofibrillary de- generation in transgenic mice expressing mutant tau and APP. Science 2001;293:1487 Y91
  42. Tsuang DW, Wilson RK, Lopez OL, et al. Genetic association between the APOE*4 allele and Lewy bodies in Alzheimer disease. Neurology 2005;64:509 Y13
  43. Lopez OL, Wisniewski S, Hamilton RL, et al. Predictors of progression in patients with AD and Lewy bodies. Neurology 2000;54:1774 Y79
  44. Heyman A, Fillenbaum GG, Gearing M, et al. Comparison of Lewy body variant of Alzheimer_s disease with pure Alzheimer_s disease: Consortium to establish a registry for Alzheimer_s disease, part XIX. Neurology 1999;52:1839 Y 44
  45. Serby M, Brickman AM, Haroutunian V, et al. Cognitive burden and excess Lewy-body pathology in the Lewy-body variant of Alzheimer disease. Am J Geriatr Psychiatry 2003;11:371 Y74
  46. Merdes AR, Hansen LA, Jeste DV, et al. Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies. Neurology 2003;60:1586 Y90

Cited by

Sorted by citations

Authors
Uchikado, H., Lin, W.-L., DeLucia, M. W., & Dickson, D. W.
Affiliations
Mayo Clinic (US)
Corresponding author
Dickson, Dennis W.
Venue
Journal of Neuropathology and Experimental Neurology
Published
2006-07
Volume
65
Issue
7
Pages
685-697
ISSN
0022-3069 (ISSN-L)
OpenAlex
W1968324269
Cited by
359
References
10
Citations by year
2026: 16 · 2025: 33 · 2024: 30 · 2023: 15 · 2022: 17 · 2021: 17 · 2020: 13 · 2019: 22 · 2018: 14 · 2017: 17 · 2016: 7 · 2015: 12 · 2014: 17 · 2013: 13 · 2012: 14
FWCI
13.73
Type
journal article
Language
en
Open access
Locations
  • Journal of Neuropathology & Experimental Neurology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Mayo Foundation for Medical Education and Research (AG17216, AG03949, AG16574, AG14449)
  • National Institutes of Health (AG03949, NS40256, AG14449, P50-AG25711, AG16574, AG17216)
  • National Institute on Aging (P50 AG25711, P50‐AG16574, P01-AG-17216, P01AG03949, P01AG014449, P01AG003949, P01 AG14449, P50AG025711, P01AG017216, P50AG016574)
  • National Institute of Neurological Disorders and Stroke (P50-NS40256, P50NS040256)
  • State of Florida
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
Alzheimer's disease, synucleinopathies, Lewy body disease, alpha-synuclein pathology, amygdala, brainstem, amyloid plaques, APOE ε4
MeSH terms
Aged, Aged, 80 and over, Alzheimer Disease, Amygdala, Demography, Female, Humans, Male, Middle Aged, Neurons, Retrospective Studies, Statistics as Topic, Lewy Bodies, Lewy Body Disease, alpha-Synuclein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review